Triad Drug Discovery Group

About Us

The Triad Drug Discovery Group (TDDG) holds open events for the scientific community in the Piedmont Triad region on topics of drug discovery sciences and biotechnology. Participants include students, postdoctoral fellows, scientists (at all levels), academic faculty, business/industry and others. The goal is to engage the scientific community from academia and industry in regular meetings to discuss hot topics in fundamental sciences in the path from biological target and/or bioactive compounds leading into preclinical lead compounds and novel drug discovery.  Meetings encourage discussions and collaborations across multiple disciplines that foster translational research and development of novel medicines.

To Get Involved

For more information about Triad Drug Discovery Group (TDDG) and upcoming meetings, please contact either Patricia Reggio at phreggio@uncg.edu or Narasinga Rao at nrao555@gmail.com.

Meeting Topics/Speakers

Previous meeting topics and speakers have included:

• Metabolomics:  a global biochemical approach to metabolic disorders & drug response - Wei Jia, Ph.D., UNCG
• Comparison of pneumococcal type 10 capsules with Streptoccocus oralisi receptor polysaccharides: The structures and genes for biosynthesis - C. Allen Bush, Professor, UMBC
• From Bark to Bench to Bedside: A personal history of the Discovery & Developmetn of Taxol - Mansukh Wani, Ph.D., Natural Products Laboratory RTP
• NMR studies of protein-protein & protein-ligand interactions - Frank Moy, Ph.D., UNCG
• From Bench to Biotech, A Fairytale: the drug discovery technology of Polymerix'Polymerdrugs  -  Alan Letton, Assoc. Vice Chancellor for Research, NCA&T
• The middle in SBTDC...Technology- the Center for Small Business & Technology Development-  David Sipple, SBTDC @ UNCG and James Miller, Jr., SBTDC @ WSSU
• The role of chemistry & biology in the discovery & development of products in Syngenta - Tim Pastoor, Syngenta Crop Protection, Inc., Greensboro
• Optimizing the synthetic methods to explore structure-activity relationships (Joint meeting with ACS Central NC Division)  -   Mitchell Croatt, Assistant Professor, UNCG
• Drug-like Properties at Design - Phillip Bowen, UNCG
• Targeted Gene Therapy - Patricia Reggio, UNCG
• Dynamic Nuclear Polarization and Monitoring of Molecular Properties - Lakshmi Kotra, UNCG
• Outsourcing in Chemical Pharmaceutical Synthesis - K. Ramaiah, Pharmacore
• Metabolism in Drug Discovery - Murty Arimilli, TMT Pharma
• Identification of Drug Targets for Synergy-based Therapeutics - Harel Weinstein, Cornell Univ.
• DMPK in Drug Development - Biao Li, Drumetix
• Navigation of Chemical Space for Drug Discovery - Narasinga Rao, Molecular Drug
  Discovery Consultant
• Chemical Patent Practice - Kody Jones, MacCord Mason
• Natural Product Drug Discovery - Nicholas Oberlies, UNCG
• Searching for Brain Cancer Biomarkers - Norman Chiu, UNCG
• Laboratory Automation for Drug Discovery and Life Sciences - Will E. Taylor, UNCG
• Ligands with Simultaneous Affinity to Multiple Targets - Tariq Andra, ScieIntel
• Molecules in Medicine - Dan Christen, High Point Univ.
• Virtual Screening in Drug Discovery - Narasinga Rao, Molecular Drug Discovery Consultant
• Drug Discovery Center of Innovation: Uncovering Intelligent Synergies, Creating Translational Solutions - John Didsbury, Drug Discovery Center of Innovation